Form 8-K - Current report:
SEC Accession No. 0001104659-21-126948
Filing Date
2021-10-18
Accepted
2021-10-18 07:06:14
Documents
12
Period of Report
2021-10-18
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2130106d2_8k.htm   iXBRL 8-K 25987
  Complete submission text file 0001104659-21-126948.txt   195914

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA avdl-20211018.xsd EX-101.SCH 3019
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE avdl-20211018_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avdl-20211018_pre.xml EX-101.PRE 22355
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2130106d2_8k_htm.xml XML 3467
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37977 | Film No.: 211327313
SIC: 2834 Pharmaceutical Preparations